Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127380042 | 12738004 | 2 | F | 20160923 | 20160913 | 20160928 | EXP | US-SA-2016SA167907 | AVENTIS | YU KK, DASANU CA. RAPIDLY FATAL DISSEMINATION OF MERKEL CELL CARCINOMA IN A PATIENT TREATED WITH ALEMTUZUMAB FOR CHRONIC LYMPHOCYTIC LEUKEMIA. CONN MED. 2016;80(6):353-8. | 76.00 | YR | E | M | Y | 0.00000 | 20160928 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127380042 | 12738004 | 1 | PS | ALEMTUZUMAB | ALEMTUZUMAB | 1 | Unknown | D | UNKNOWN | 103948 | |||||||||
| 127380042 | 12738004 | 2 | SS | FLUDARABINE PHOSPHATE. | FLUDARABINE PHOSPHATE | 1 | Unknown | D | UNKNOWN | 20038 | |||||||||
| 127380042 | 12738004 | 3 | C | INSULIN | INSULIN NOS | 1 | 0 | ||||||||||||
| 127380042 | 12738004 | 4 | C | ACYCLOVIR. | ACYCLOVIR | 1 | Oral | 0 | |||||||||||
| 127380042 | 12738004 | 5 | C | DOXEPIN | DOXEPIN | 1 | 0 | ||||||||||||
| 127380042 | 12738004 | 6 | C | ROSUVASTATIN. | ROSUVASTATIN | 1 | 0 | ||||||||||||
| 127380042 | 12738004 | 7 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
| 127380042 | 12738004 | 8 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 | ||||||||||||
| 127380042 | 12738004 | 9 | C | FOLIC ACID. | FOLIC ACID | 1 | 0 | ||||||||||||
| 127380042 | 12738004 | 10 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127380042 | 12738004 | 1 | Chronic lymphocytic leukaemia |
| 127380042 | 12738004 | 2 | Chronic lymphocytic leukaemia |
| 127380042 | 12738004 | 10 | Supplementation therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127380042 | 12738004 | DE |
| 127380042 | 12738004 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127380042 | 12738004 | Arthralgia | |
| 127380042 | 12738004 | Breast mass | |
| 127380042 | 12738004 | Chest wall mass | |
| 127380042 | 12738004 | Dyspnoea | |
| 127380042 | 12738004 | Hepatic mass | |
| 127380042 | 12738004 | Hypogammaglobulinaemia | |
| 127380042 | 12738004 | Lymphopenia | |
| 127380042 | 12738004 | Malignant pleural effusion | |
| 127380042 | 12738004 | Mediastinal mass | |
| 127380042 | 12738004 | Metastatic neoplasm | |
| 127380042 | 12738004 | Neuroendocrine carcinoma of the skin | |
| 127380042 | 12738004 | Paraesthesia | |
| 127380042 | 12738004 | Purulent discharge | |
| 127380042 | 12738004 | Skin mass |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |